We are live on
!
Find out more
Mariner Portfolio holdings
AUM
$85.7B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
+11.61%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$69.3B
AUM Growth
+$9.18B
(+15%)
Cap. Flow
+$3.47B
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
26.5%
Holding
3,740
New
311
Increased
1,893
Reduced
1,169
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$261M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
GE Vernova
GEV
|
+$143M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$107M |
| 5 |
JPMorgan Chase
JPM
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$83.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$78.6M |
| 3 |
General Mills
GIS
|
+$42.3M |
| 4 |
Target
TGT
|
+$27.6M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.78% |
| 2 | Financials | 8.14% |
| 3 | Consumer Discretionary | 5.23% |
| 4 | Healthcare | 4.75% |
| 5 | Communication Services | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRF
3151
Cornerstone Total Return Fund
CRF
$1.14B
| $148K | ﹤0.01% |
19,073
+1,700
| +10% | +$12.1K |
|
|
SBI
3152
Western Asset Intermediate Muni Fund
SBI
$109M
| $148K | ﹤0.01% |
19,618
| – | – |
|
3153
Ramaco Resources Class A
METC
$676M
| $147K | ﹤0.01% |
+11,174
| New | +$107K |
|
3154
Nu Skin
NUS
$247M
| $146K | ﹤0.01% |
18,291
-2,884
| -14% | -$20.2K |
|
3155
Bausch Health
BHC
$1.65B
| $146K | ﹤0.01% |
21,910
+9,949
| +83% | +$51.1K |
|
3156
Arcutis Biotherapeutics
ARQT
$3.42B
| $145K | ﹤0.01% |
+10,343
| New | +$145K |
|
3157
Leggett & Platt
LEG
$1.52B
| $144K | ﹤0.01% |
16,197
-1,822
| -10% | -$15.7K |
|
3158
Alvotech
ALVO
$1.03B
| $144K | ﹤0.01% |
15,775
-7,930
| -33% | -$74.4K |
|
3159
TeraWulf
WULF
$9.15B
| $143K | ﹤0.01% |
32,753
-11,135
| -25% | -$38K |
|
3160
Jasper Therapeutics
JSPR
$22.9M
| $142K | ﹤0.01% |
25,513
-5,677
| -18% | -$28K |
|
3161
Fastly Inc
FSLY
$3.17B
| $142K | ﹤0.01% |
20,045
-3,952
| -16% | -$26.5K |
|
|
UNIT
3162
Uniti Group
UNIT
$2.63B
| $141K | ﹤0.01% |
32,712
+12,683
| +63% | +$57K |
|
3163
Granite Ridge Resources
GRNT
$640M
| $141K | ﹤0.01% |
22,170
+1,418
| +7% | +$7.81K |
|
3164
Verrica Pharmaceuticals
VRCA
$86.2M
| $141K | ﹤0.01% |
26,530
+10,011
| +61% | +$53.9K |
|
3165
Akebia Therapeutics
AKBA
$327M
| $140K | ﹤0.01% |
38,326
+557
| +1% | +$1.53K |
|
3166
UWM Holdings
UWMC
$621M
| $139K | ﹤0.01% |
33,582
-31,121
| -48% | -$137K |
|
3167
Ivanhoe Electric
IE
$1.43B
| $139K | ﹤0.01% |
15,303
-10,533
| -41% | -$73.1K |
|
3168
Oil States International
OIS
$522M
| $138K | ﹤0.01% |
25,767
+8,058
| +46% | +$35.6K |
|
3169
NextDecade
NEXT
$1.85B
| $137K | ﹤0.01% |
15,426
-4,160
| -21% | -$32.3K |
|
3170
Pebblebrook Hotel Trust
PEB
$2.16B
| $137K | ﹤0.01% |
+13,754
| New | +$128K |
|
3171
PennantPark Floating Rate Capital
PFLT
$681M
| $137K | ﹤0.01% |
+13,296
| New | +$135K |
|
3172
Rallybio
RLYB
$86.6M
| $137K | ﹤0.01% |
50,568
| – | – |
|
3173
Green Plains
GPRE
$1.19B
| $137K | ﹤0.01% |
22,665
+4,494
| +25% | +$19.8K |
|
3174
Invesco California Value Municipal Income Trust
VCV
$515M
| $136K | ﹤0.01% |
13,146
-1,451
| -10% | -$14.9K |
|
3175
Intellia Therapeutics
NTLA
$1.5B
| $136K | ﹤0.01% |
14,507
-2,046
| -12% | -$16.8K |
|
Similar funds
Mariner's Q2 2025 Portfolio in Review
As of Q2 2025, Mariner held 3,740 positions worth $69.3B, up 15% from $60.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Mariner deployed $3.47B of net new capital in Q2 2025, opening 311 new positions and adding to 1,893 existing holdings. Its largest new stake was iShares MSCI USA Small-Cap Min Vol Factor ETF: 384,640 shares worth $16.2M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Union Pacific, an estimated $83.9M trimmed.
- Mariner's largest Q2 2025 buy was iShares MSCI USA Small-Cap Min Vol Factor ETF: 384,640 shares worth $16.2M.
- Mariner added most to Apple in Q2 2025, an estimated $261M increase.
- Mariner's biggest Q2 2025 reduction was Union Pacific, cutting an estimated $83.9M.
- Mariner fully exited Discover Financial Services in Q2 2025, selling an estimated $7.86M.
- Mariner's ten largest holdings make up 26% of its $69.3B portfolio in Q2 2025.
- Mariner opened 311 new positions and closed 273 in Q2 2025.
- Mariner's portfolio value rose 15% quarter-over-quarter to $69.3B.
Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.